1,137
Views
45
CrossRef citations to date
0
Altmetric
Review Article

LOX/LOXL in pulmonary fibrosis: potential therapeutic targets

, &
Pages 790-796 | Received 12 Sep 2018, Accepted 12 Nov 2018, Published online: 29 Nov 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Alessandro Garcia Lopes, Gildásio Castello de Almeida Jr, Marcos Paulo Miola, Ronan Marques Teixeira, Francielly Camilla Bazilio Laurindo Pires, Rodolfo Andrade Miani, Luiz Carlos de Mattos, Cinara Cássia Brandão & Lilian Castiglioni. (2022) Absence of significant genetic alterations in the VSX1, SOD1, TIMP3, and LOX genes in Brazilian patients with Keratoconus. Ophthalmic Genetics 43:1, pages 73-79.
Read now
Martin Pehrsson, Joachim Høg Mortensen, Tina Manon-Jensen, Anne-Christine Bay-Jensen, Morten Asser Karsdal & Michael Jonathan Davies. (2021) Enzymatic cross-linking of collagens in organ fibrosis – resolution and assessment. Expert Review of Molecular Diagnostics 21:10, pages 1049-1064.
Read now

Articles from other publishers (43)

Ioannis Tomos, Ioannis Roussis, Andreas M. Matthaiou & Katerina Dimakou. (2023) Molecular and Genetic Biomarkers in Idiopathic Pulmonary Fibrosis: Where Are We Now?. Biomedicines 11:10, pages 2796.
Crossref
Jun Chang, Shaoqing Zou, Yiwen Xiao & Du Zhu. (2023) Identification and validation of targets of swertiamarin on idiopathic pulmonary fibrosis through bioinformatics and molecular docking-based approach. BMC Complementary Medicine and Therapies 23:1.
Crossref
Sergey Shuvaev, Rachel S. Knipe, Matt Drummond, Nicholas J. Rotile, Ilknur Ay, Jonah P. Weigand-Whittier, Hua Ma, Iris Yuwen Zhou, Jesse D. RobertsJrJr, Katherine Black, Lida P. Hariri, Yingying Ning & Peter Caravan. (2023) Optimization of an Allysine-Targeted PET Probe for Quantifying Fibrogenesis in a Mouse Model of Pulmonary Fibrosis. Molecular Imaging and Biology 25:5, pages 944-953.
Crossref
Alan Poe, Marta Martinez Yus, Huilei Wang & Lakshmi Santhanam. (2023) Lysyl oxidase like-2 in fibrosis and cardiovascular disease. American Journal of Physiology-Cell Physiology 325:3, pages C694-C707.
Crossref
Xinru Xue, Xi Zeng, Xiaoqian Wu, Kexin Mu, Yue Dai & Zhifeng Wei. (2023) SIRT4 protects against intestinal fibrosis by facilitating GLS1 degradation. Matrix Biology 122, pages 33-45.
Crossref
Mingchen Xu, Chenghe Zhao, Haiming Song, Chunmei Wang, He Li, Xudong Qiu, He Jing & Wenyue Zhuang. (2023) Inhibitory effects of Schisandrin C on collagen behavior in pulmonary fibrosis. Scientific Reports 13:1.
Crossref
Annika Hummersgaard Hansen, Helene Wallem Breisnes, Thomas Skovhus Prior, Ole Hilberg, Daniel Guldager Kring Rasmussen, Federica Genovese, Marie Vestergaard Lukassen, Birte Svensson, Lasse Løcke Langholm, Tina Manon-Jensen, Morten Asser Karsdal, Diana Julie Leeming, Elisabeth Bendstrup & Jannie Marie Bülow Sand. (2023) A serologically assessed neo-epitope biomarker of cellular fibronectin degradation is related to pulmonary fibrosis. Clinical Biochemistry 118, pages 110599.
Crossref
Kristy M. Waldrep, Jessalyn I. Rodgers, Sara M. Garrett, Bethany J. Wolf & Carol A. Feghali-Bostwick. (2023) The Role of SOX9 in IGF-II-Mediated Pulmonary Fibrosis. International Journal of Molecular Sciences 24:14, pages 11234.
Crossref
Man Yuan, Xiaoxian Lin, Dongliang Wang & Jianye Dai. (2023) Proteins: Neglected active ingredients in edible bird’s nest. Chinese Herbal Medicines 15:3, pages 383-390.
Crossref
Huilei Wang, Alan Poe, Marta Martinez Yus, Lydia Pak, Kavitha Nandakumar & Lakshmi Santhanam. (2023) Lysyl oxidase-like 2 processing by factor Xa modulates its activity and substrate preference. Communications Biology 6:1.
Crossref
Gwenda F. Vasse, Sara Russo, Andrei Barcaru, Asmaa A. A. Oun, Amalia M. Dolga, Patrick van Rijn, Marcel Kwiatkowski, Natalia Govorukhina, Rainer Bischoff & Barbro N. Melgert. (2023) Collagen type I alters the proteomic signature of macrophages in a collagen morphology-dependent manner. Scientific Reports 13:1.
Crossref
Guoqing Ren, Gonghao Xu, Renshi Li, Haifeng Xie, Zhengguo Cui, Lei Wang & Chaofeng Zhang. (2023) Modulation of Bleomycin-induced Oxidative Stress and Pulmonary Fibrosis by Ginkgetin in Mice via AMPK. Current Molecular Pharmacology 16:2, pages 217-227.
Crossref
Chan Xie, Bixin Tang, Kunlun Wu, Qingyi Meng & Fang Wang. (2022) Increased serum LOXL2 concentration in pelvic inflammatory disease with pelvic adhesion. BMC Women's Health 22:1.
Crossref
Benjamin H. Jenkins, Josephine F. Buckingham, Christopher J. Hanley & Gareth J. Thomas. (2022) Targeting cancer-associated fibroblasts: Challenges, opportunities and future directions. Pharmacology & Therapeutics 240, pages 108231.
Crossref
Yang Miao, Xiaohe Li, Yue Yang, Jianwei Zhang, Li Chen, Qianyi Zhang, Wenqi Li, Ying Liu, Xianfeng Zhang, Ruimin Gu & Cheng Yang. (2022) Entrectinib ameliorates bleomycin-induced pulmonary fibrosis in mice by inhibiting TGF-β1 signaling pathway. International Immunopharmacology 113, pages 109427.
Crossref
Sanja Stankovic, Mihailo Stjepanovic & Milika Asanin. 2022. Idiopathic Pulmonary Fibrosis. Idiopathic Pulmonary Fibrosis.
Rong Li, Runze Shang, Shunle Li, Yifan Ren, Lin Shen, Longbao Yang, Shuo Chen, Xi Chen, Junhui Li & Meng Xu. (2022) LOXL3 ‐promoted hepatocellular carcinoma progression via promotion of Snail1/ USP4 ‐mediated epithelial‐mesenchymal transition . Environmental Toxicology 37:10, pages 2540-2551.
Crossref
Talita de Sousa Laurentino, Roseli da Silva Soares, Suely Kazue Nagahashi Marie & Sueli Mieko Oba-Shinjo. (2022) Correlation of Matrisome-Associatted Gene Expressions with LOX Family Members in Astrocytomas Stratified by IDH Mutation Status. International Journal of Molecular Sciences 23:17, pages 9507.
Crossref
Xiaoqin Zhang, Wenqian Zhou, Yangyang Niu, Saiya Zhu, Yingying Zhang, Xiaogang Li & Chen Yu. (2022) Lysyl oxidase promotes renal fibrosis via accelerating collagen cross‐link driving by β‐arrestin/ ERK / STAT3 pathway . The FASEB Journal 36:8.
Crossref
Hongbo Ma, Xuyi Wu, Yi Li & Yong Xia. (2022) Research Progress in the Molecular Mechanisms, Therapeutic Targets, and Drug Development of Idiopathic Pulmonary Fibrosis. Frontiers in Pharmacology 13.
Crossref
Xiaoxiao Xu, Chuang Ma, Hang Wu, Yuanqiao Ma, Zejin Liu, Peijie Zhong, Chaolei Jin, Wenjuan Ning, Xiao Wu, Yijie Zhang, Jichang Han & Junpeng Wang. (2022) Fructose Induces Pulmonary Fibrotic Phenotype Through Promoting Epithelial-Mesenchymal Transition Mediated by ROS-Activated Latent TGF-β1. Frontiers in Nutrition 9.
Crossref
Lara Perryman & Steven G. Gray. (2022) Fibrosis in Mesothelioma: Potential Role of Lysyl Oxidases. Cancers 14:4, pages 981.
Crossref
Jan C. Kamp, Lavinia Neubert, Helge Stark, Jan B. Hinrichs, Caja Boekhoff, Allison D. Seidel, Fabio Ius, Axel Haverich, Jens Gottlieb, Tobias Welte, Peter Braubach, Florian Laenger, Marius M. Hoeper, Mark P. Kuehnel & Danny D. Jonigk. (2022) Comparative Analysis of Gene Expression in Fibroblastic Foci in Patients with Idiopathic Pulmonary Fibrosis and Pulmonary Sarcoidosis. Cells 11:4, pages 664.
Crossref
Hongbo Ma, Xuyi Wu, Yi Li & Yong Xia. (2022) Avances en la investigación de los mecanismos moleculares, los blancos terapéuticos y el desarrollo de fármacos para la fibrosis pulmonar idiopática. Kompass Neumología 4:3, pages 129-146.
Crossref
Alison W Ha, Tao Bai, David L Ebenezer, Tanvi Sethi, Tara Sudhadevi, Lizar Ace Mangio, Steven Garzon, Gloria S Pryhuber, Viswanathan Natarajan & Anantha Harijith. (2022) Sphingosine kinase 1 regulates lysyl oxidase through STAT3 in hyperoxia-mediated neonatal lung injury. Thorax 77:1, pages 47-57.
Crossref
Suchitra Kumari, A. Raj Kumar Patro, Baijayantimala Mishra, Saubhagya Kumar Jena & Sweta Singh. (2021) Serum Lysyl Oxidase Levels and Lysyl Oxidase Gene Polymorphism in Ovarian Cancer Patients of Eastern Indian Population. Diagnostics 12:1, pages 53.
Crossref
Xiang Tong, Shijie Zhang, Dongguang Wang, Li Zhang, Jizheng Huang, Tianli Zhang & Hong Fan. (2021) Azithromycin Attenuates Bleomycin-Induced Pulmonary Fibrosis Partly by Inhibiting the Expression of LOX and LOXL-2. Frontiers in Pharmacology 12.
Crossref
Shireen Attaran, John J. Skoko, Barbara L. Hopkins, Megan K. Wright, Laurel E. Wood, Alparslan Asan, Hyun Ae Woo, Adam Feinberg & Carola A. Neumann. (2021) Peroxiredoxin-1 Tyr194 phosphorylation regulates LOX-dependent extracellular matrix remodelling in breast cancer. British Journal of Cancer 125:8, pages 1146-1157.
Crossref
Juan Manuel Velázquez-Enríquez, Jovito Cesar Santos-Álvarez, Alma Aurora Ramírez-Hernández, Edilburga Reyes-Jiménez, Armando López-Martínez, Socorro Pina-Canseco, Sergio Roberto Aguilar-Ruiz, María de los Ángeles Romero-Tlalolini, Luis Castro-Sánchez, Jaime Arellanes-Robledo, Verónica Rocío Vásquez-Garzón & Rafael Baltiérrez-Hoyos. (2021) Proteomic Analysis Reveals Key Proteins in Extracellular Vesicles Cargo Associated with Idiopathic Pulmonary Fibrosis In Vitro. Biomedicines 9:8, pages 1058.
Crossref
Nina Noskovicova, Boris Hinz & Pardis Pakshir. (2021) Implant Fibrosis and the Underappreciated Role of Myofibroblasts in the Foreign Body Reaction. Cells 10:7, pages 1794.
Crossref
Huilei Wang, Alan Poe, Lydia Pak, Kavitha Nandakumar, Sandeep Jandu, Jochen Steppan, Reik Löser & Lakshmi Santhanam. (2021) An in situ activity assay for lysyl oxidases. Communications Biology 4:1.
Crossref
Elisabeth Prince, Zhengkun Chen, Nancy Khuu & Eugenia Kumacheva. (2021) Nanofibrillar Hydrogel Recapitulates Changes Occurring in the Fibrotic Extracellular Matrix. Biomacromolecules 22:6, pages 2352-2362.
Crossref
Ruo-Fei Li, Xin-Yue Chen, Yong Xu, Fan-Chao Feng, Hai-Lang He & Xian-Mei Zhou. (2021) Inhibitory effects of alkaline extract from the pericarp of Citrus reticulata Blanco on collagen behavior in bleomycin-induced pulmonary fibrosis. Journal of Ethnopharmacology 269, pages 113761.
Crossref
Katarzyna Wolska-Gawron, Joanna Bartosińska, Marta Rusek, Małgorzata Kowal, Dorota Raczkiewicz & Dorota Krasowska. (2020) Circulating miRNA-181b-5p, miRNA-223-3p, miRNA-210-3p, let 7i-5p, miRNA-21-5p and miRNA-29a-3p in patients with localized scleroderma as potential biomarkers. Scientific Reports 10:1.
Crossref
Sai Balaji Andugulapati, Karthik Gourishetti, Satya Krishna Tirunavalli, Taslim Babru Shaikh & Ramakrishna Sistla. (2020) Biochanin-A ameliorates pulmonary fibrosis by suppressing the TGF-β mediated EMT, myofibroblasts differentiation and collagen deposition in in vitro and in vivo systems. Phytomedicine 78, pages 153298.
Crossref
Rabia Johnson, Xolisa Nxele, Martin Cour, Nonhlakanipho Sangweni, Tracey Jooste, Nkanyiso Hadebe, Ebrahim Samodien, Mongi Benjeddou, Mikateko Mazino, Johan Louw & Sandrine Lecour. (2020) Identification of potential biomarkers for predicting the early onset of diabetic cardiomyopathy in a mouse model. Scientific Reports 10:1.
Crossref
F. Anthony Romero, Christopher T. Jones, Yingzi Xu, Martijn Fenaux & Randall L. Halcomb. (2020) The Race to Bash NASH: Emerging Targets and Drug Development in a Complex Liver Disease. Journal of Medicinal Chemistry 63:10, pages 5031-5073.
Crossref
Shanzun Wei, Liang Gao, Changjing Wu, Feng Qin & Jiuhong Yuan. (2020) Role of the lysyl oxidase family in organ development (Review). Experimental and Therapeutic Medicine 20:1, pages 163-172.
Crossref
Ravit Gabay Yehezkely, Shelly Zaffryar-Eilot, Anna Kaganovsky, Nurit Fainshtain Malka, Rohtem Aviram, Ido Livneh & Peleg Hasson. (2020) Intracellular Role for the Matrix-Modifying Enzyme Lox in Regulating Transcription Factor Subcellular Localization and Activity in Muscle Regeneration. Developmental Cell 53:4, pages 406-417.e5.
Crossref
Silvia Baldari, Giuliana Di Rocco & Gabriele Toietta. (2020) Current Biomedical Use of Copper Chelation Therapy. International Journal of Molecular Sciences 21:3, pages 1069.
Crossref
Alison D. Findlay, Jonathan S. Foot, Alberto Buson, Mandar Deodhar, Andrew G. Jarnicki, Philip M. Hansbro, Gang Liu, Heidi Schilter, Craig I. Turner, Wenbin Zhou & Wolfgang Jarolimek. (2019) Identification and Optimization of Mechanism-Based Fluoroallylamine Inhibitors of Lysyl Oxidase-like 2/3. Journal of Medicinal Chemistry 62:21, pages 9874-9889.
Crossref
Tianliang Bai, Yabin Liu & Binghui Li. (2019) LncRNA LOXL1‐AS1/miR‐let‐7a‐5p/ EGFR ‐related pathway regulates the doxorubicin resistance of prostate cancer DU‐145 cells . IUBMB Life 71:10, pages 1537-1551.
Crossref
Talita de S. Laurentino, Roseli da S. Soares, Suely K. N. Marie & Sueli M. Oba-Shinjo. (2019) LOXL3 Function Beyond Amino Oxidase and Role in Pathologies, Including Cancer. International Journal of Molecular Sciences 20:14, pages 3587.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.